Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02969343 · ClinicalTrials.gov registry record · NA
Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered
A NA study of Venous Thromboembolism and Adverse Drug Event, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 21,000
- Enrollment target
- 1
- Study location
NCT02969343 is a NA study of Venous Thromboembolism and Adverse Drug Event that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 21,000 participants, above the 5,849-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (259% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02969343, a NA study of Venous Thromboembolism and Adverse Drug Event, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 21,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Brigham and Women's Hospital (BWH) Patient Safety Learning Laboratory (PSLL) focuses on developing health information technology (HIT) tools to engage patients, family, and professional care team members in reliable identification, assessment, and reduction of patient safety threats in real-time, before they manifest in actual harm.
Conditions Studied
Interventions
- BEHAVIORAL Patient Safety health information technology
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21,000 participants |
| Start Date | 2015-04 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02969343
The ClinicalTrials.gov registry entry for NCT02969343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 5,849-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (259% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Venous Thromboembolism appearing as the primary indexed condition, and to 1 intervention - of which Patient Safety health information technology is the first listed.
NCT02969343 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02969343 about?
NCT02969343 is a clinical study titled "Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered". The Brigham and Women's Hospital (BWH) Patient Safety Learning Laboratory (PSLL) focuses on developing health information technology (HIT) tools to engage patients, family, and professional care team members in reliable identification, assessment, and reduction of patient safety threats in real-time...
What is the current status of trial NCT02969343?
This trial is currently completed. It is a NA study. The enrollment target is 21,000 participants. The study started on 2015-04. Estimated completion is 2018-12.
What conditions does trial NCT02969343 study?
This clinical trial studies the following conditions: Venous Thromboembolism, Adverse Drug Event, Severe Hypoglycemia, Hospital Acquired Pressure Ulcer, Central Line-Associated Bloodstream Infection (CLABSI).
What interventions are being tested in trial NCT02969343?
The interventions under investigation include: Patient Safety health information technology (BEHAVIORAL).
Who is sponsoring clinical trial NCT02969343?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02969343 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thromboembolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
RECRUITING · NA
-
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
RECRUITING · NA
-
Warfarin Patient Self-management Implementation in the US Healthcare System
RECRUITING · NA
-
CLEANer Aspiration for Pulmonary Embolism
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.